收费全文 | 368813篇 |
免费 | 11158篇 |
国内免费 | 839篇 |
耳鼻咽喉 | 3504篇 |
儿科学 | 12728篇 |
妇产科学 | 7780篇 |
基础医学 | 43833篇 |
口腔科学 | 7736篇 |
临床医学 | 27230篇 |
内科学 | 75298篇 |
皮肤病学 | 6015篇 |
神经病学 | 33524篇 |
特种医学 | 13091篇 |
外国民族医学 | 3篇 |
外科学 | 49451篇 |
综合类 | 3107篇 |
一般理论 | 74篇 |
预防医学 | 38668篇 |
眼科学 | 6544篇 |
药学 | 23572篇 |
中国医学 | 1325篇 |
肿瘤学 | 27327篇 |
2023年 | 1435篇 |
2022年 | 2111篇 |
2021年 | 5199篇 |
2020年 | 3048篇 |
2019年 | 4902篇 |
2018年 | 27616篇 |
2017年 | 21088篇 |
2016年 | 23527篇 |
2015年 | 6245篇 |
2014年 | 7405篇 |
2013年 | 10148篇 |
2012年 | 21564篇 |
2011年 | 35593篇 |
2010年 | 26356篇 |
2009年 | 17715篇 |
2008年 | 31222篇 |
2007年 | 33692篇 |
2006年 | 12469篇 |
2005年 | 13671篇 |
2004年 | 13840篇 |
2003年 | 13797篇 |
2002年 | 11234篇 |
2001年 | 3917篇 |
2000年 | 4100篇 |
1999年 | 3379篇 |
1998年 | 1450篇 |
1997年 | 1126篇 |
1996年 | 946篇 |
1995年 | 795篇 |
1994年 | 719篇 |
1993年 | 572篇 |
1992年 | 1573篇 |
1991年 | 1417篇 |
1990年 | 1390篇 |
1989年 | 1210篇 |
1988年 | 1095篇 |
1987年 | 1063篇 |
1986年 | 998篇 |
1985年 | 921篇 |
1984年 | 728篇 |
1983年 | 606篇 |
1979年 | 661篇 |
1978年 | 423篇 |
1974年 | 598篇 |
1973年 | 520篇 |
1972年 | 455篇 |
1971年 | 410篇 |
1970年 | 504篇 |
1969年 | 464篇 |
1968年 | 436篇 |
Background
Hyperglycaemia is common in patients with acute brain injury admitted to an intensive care unit (ICU). Many studies have found associations between development of hyperglycaemia and increased mortality in hospitalised patients. However, the optimal target for blood glucose control is unknown. We want to conduct a systematic review with meta-analysis and trial sequential analysis to explore the beneficial and harmful effects of restrictive versus liberal glucose control on patient outcomes in adults with severe acute brain injury.Methods
We will systematically search medical databases including CENTRAL, Embase, MEDLINE and trial registries. We will search the following websites for ongoing or unpublished trials: http://www.controlled-trials.com/ , http://www.clinicaltrials.gov/ , www.eudraCT.com , http://centerwatch.com/ , The Cochrane Library's CENTRAL, PubMed, EMBASE, Science Citation Index Expanded and CINAHL. Two authors will independently review and select trials and extract data. We will include randomised trials comparing levels of glucose control in our analyses and observational studies will be included to address potential harms. The primary outcomes are defined as all-cause mortality, functional outcome and health-related quality of life. Secondary outcomes include serious adverse events including hypoglycaemia, length of ICU stay and duration of mechanical ventilation, and explorative outcomes including intracranial pressure and infection. Trial Sequential Analysis will be used to investigate the risk of type I error due to repetitive testing and to further explore imprecision. Quality of trials will be evaluated using the Cochrane Risk of Bias tool, and quality of evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach.Discussion
The results of the systematic review will be disseminated through peer-reviewed publication. With the review, we hope to inform future randomised clinical trials and improve clinical practice. 相似文献Areas covered: This article reviews the major preclinical and clinical data on PDE5 inhibitors with a specific focus on tadalafil. It includes details of the role of the nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) – PDE5 pathway in the LUT organs (bladder and prostate) in addition to the available data on tadalafil in patients with LUTS secondary to BPH with or without erectile dysfunction (ED).
Expert opinion: Preclinical and clinical data have clearly demonstrated that PDE5 inhibitors induce bladder and prostate relaxation, which contributes to the improvement seen in storage symptoms in both animal models of bladder and prostate hypercontractility. Tadalafil is effective both as a monotherapy and add-on therapy in patients with LUTS secondary to BPH. Furthermore, as LUTS-BPH and ED are urological disorders that commonly coexist in aging men, tadalafil is more advantageous than α1-adrenoceptors and should be used as the first option. Tadalafil is a safe and tolerable therapy and unlike α1- adrenoceptors and 5-alpha reductase inhibitors, which can cause sexual dysfunctions, tadalafil improves sexual function. 相似文献
Areas covered: This review includes a view of the clinical classification and risk assessment in children suffering from HL. The chemotherapy more commonly employed is revisited. The use of PET/CT to evaluate the disease in order to guide therapy is analyzed. New options of chemotherapy and emerging immunotherapy are also included.
Expert opinion: In order to make the right treatment choice, a proper initial assessment of risk is mandatory. The choice of therapy in these kinds of patients must be done according to the experience of the team, and also, the cost and logistics related to the eligible scheme are very important. If possible, efforts must be made to include PET/CT in guiding therapy and avoiding overtreatment and long-term adverse effects in children. New options in immunotherapy are emerging and must be considered with caution in selected patients. 相似文献